Companies 'feel betrayed' due to capping of Covid-19 vaccine price: Kiran Mazumdar Shaw
Biocon Chairperson Kiran Mazumdar Shaw on Sunday hit out at the government capping Covid-19 vaccine price at Rs 250 at private hospitals, saying vac28-02-2021
Companies 'feel betrayed' due to capping of Covid-19 vaccine price: Kiran Mazumdar Shaw
Biocon Chairperson Kiran Mazumdar Shaw on Sunday hit out at the government capping Covid-19 vaccine price at Rs 250 at private hospitals, saying vacBIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor MeetingsBIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor MeetingsBIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor MeetingCentenary Celebrations of insulin: Biocon Biologics to partner with International Diabetes Federation
The partnership with IDF coincides with the start of the centenary celebrations of the discovery of insulin and takes forward Biocon Biologics' mission of enabling affordable access to insulins to people with diabetes worldwideBIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management WorldwideBIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor MeetingBiocon Biologics, Viatris gets European Commission nod for co-developed diabetes drug
Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has got marketing authorisation approval from the European Commission for Kixelle - a biosimilar InsBIOCON LTD. - 532523 - Company Statement Titled "Biocon Biologics And Viatris Receive European Commission Approval For Kixelle, Biosimilar Insulin Aspart'.
Biocon Biologics and Viatris Receive European Commission Approval for Kixelle, Biosimilar Insulin Aspart'.BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meeting